Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Cash from Financing Activities: 2010-2024

Historic Cash from Financing Activities for SELLAS Life Sciences Group (SLS) over the last 15 years, with Dec 2024 value amounting to $46.8 million.

  • SELLAS Life Sciences Group's Cash from Financing Activities rose 36362.96% to $19.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $50.1 million, marking a year-over-year increase of 152.47%. This contributed to the annual value of $46.8 million for FY2024, which is 109.54% up from last year.
  • Latest data reveals that SELLAS Life Sciences Group reported Cash from Financing Activities of $46.8 million as of FY2024, which was up 109.54% from $22.3 million recorded in FY2023.
  • Over the past 5 years, SELLAS Life Sciences Group's Cash from Financing Activities peaked at $46.8 million during FY2024, and registered a low of $12.1 million during FY2021.
  • Moreover, its 3-year median value for Cash from Financing Activities was $24.1 million (2022), whereas its average is $31.1 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 68.59% in 2021, then surged by 109.54% in 2024.
  • Over the past 5 years, SELLAS Life Sciences Group's Cash from Financing Activities (Yearly) stood at $38.4 million in 2020, then crashed by 68.59% to $12.1 million in 2021, then soared by 99.43% to $24.1 million in 2022, then dropped by 7.33% to $22.3 million in 2023, then skyrocketed by 109.54% to $46.8 million in 2024.